Clinical Trial Update: Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 trial from University of Maryland examining how androgen deprivation therapy interacts with circadian rhythm and physiological responsivene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (Androgen deprivation therapy)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Prostatic Neoplasm, Survivorship | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING